BMY
56
-4
O
20
-2
M
52
-3
AES
47
3
INTC
36
-5
FITB
53
-5
HSIC
56
-3
BIIB
40
-2
GD
44
3
HON
64
-4
NVDA
56
2
PYPL
50
-6
WM
76
-3
KHC
15
-2
BF.B
35
-4
MOS
53
-2
SYY
53
-3
VRSK
73
-7
AVGO
32
2
RHI
54
-5
BMY
56
-4
O
20
-2
M
52
-3
AES
47
3
INTC
36
-5
FITB
53
-5
HSIC
56
-3
BIIB
40
-2
GD
44
3
HON
64
-4
NVDA
56
2
PYPL
50
-6
WM
76
-3
KHC
15
-2
BF.B
35
-4
MOS
53
-2
SYY
53
-3
VRSK
73
-7
AVGO
32
2
RHI
54
-5
Financhill
Back

PT Bank Central Asia Tbk Vs. Janux Therapeutics Industry Stock Comparison

Sell
45

PBCRY
PT Bank Central Asia Tbk

Last Price:
16.04
Seasonality Move:
5.04%
Sell
34

JANX
Janux Therapeutics

Last Price:
66.94
Seasonality Move:
133.13%
Sell
45
PT Bank Central Asia Tbk (PBCRY) is a Sell

Is PT Bank Central Asia Tbk a Buy, Sell or Hold?

  • The current PT Bank Central Asia Tbk [PBCRY] share price is $15.69. The Score for PBCRY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PBCRY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $59.86. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PBCRY Stock Price Chart

What is PT Bank Central Asia Tbk's stock price today?

  • The PT Bank Central Asia Tbk share price today is $15.69
    The current trend is relatively stagnant and PBCRY is experiencing selling pressure, which indicates risk of future bearish movement.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $59.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

PBCRY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 44.75 Sell
Chaikin Money Flow: -31665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.54 - 16.54) Sell
Bollinger Bands (100): (15.7 - 17.08) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.63 Sell
Relative Strength Index (14 RSI): 63.62 Buy
Chaikin Money Flow: -6955717 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.07 - 55.53) Buy
Bollinger Bands (100): (41.63 - 51.75) Buy

PBCRY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.61 Buy
20-day SMA: 15.86 Sell
50-day SMA: 16.56 Sell
200-day SMA: 15.82 Sell
8-day EMA: 15.64 Buy
20-day EMA: 15.88 Sell
50-day EMA: 16.23 Sell
200-day EMA: 15.88 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.16 Buy
20-day SMA: 50.4 Buy
50-day SMA: 49.88 Buy
200-day SMA: 44.87 Buy
8-day EMA: 49.16 Buy
20-day EMA: 49.72 Buy
50-day EMA: 49.41 Buy
200-day EMA: 41.75 Buy

PT Bank Central Asia Tbk Earnings Growth & PBCRY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.91 per share.

PT Bank Central Asia Tbk Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):